Inflammation and depression: Is there a causal connection with dementia?

Epidemiological studies show that there is a correlation between chronic depression and the likelihood of dementia in later life. There is evidence that inflammatory changes in the brain are pathological features of both depression and dementia. This suggests that an increase in inflammation-induced apoptosis, together with a reduction in the synthesis of neurotrophic factors caused by a rise in brain glucocorticoids, may play a role in the pathology of these disorders. A reduction in the neuroprotective components of the kynurenine pathway, such as kynurenic acid, and an increase in the neurodegenerative components, 3-hydroxykynurenine and quinolinic acid, contribute to the pathological changes. Such changes are postulated to cause neuronal damage and thereby predispose chronically depressed patients to dementia.

[1]  Roger M. Nitsch,et al.  Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion (*) , 1996, The Journal of Biological Chemistry.

[2]  B. Roth,et al.  Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression∗ ∗ See accompanying Editorial, in this issue. , 1999, Biological Psychiatry.

[3]  F. Jessen,et al.  Early-Onset and Late-Onset Depression Are Independent of the Genetic Polymorphism of Apolipoprotein E , 1999, Dementia and Geriatric Cognitive Disorders.

[4]  D. Munn,et al.  Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? , 1999, Immunology today.

[5]  J. Mendlewicz,et al.  Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex , 1997, British Journal of Psychiatry.

[6]  D. Steffens,et al.  ApoE genotype and hippocampal volume change in geriatric depression , 2002, Biological Psychiatry.

[7]  H. Wagner,et al.  Hippocampal volume and incident dementia in geriatric depression. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[8]  S. Southwick,et al.  Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. , 2000, The American journal of psychiatry.

[9]  M. Raichle,et al.  Subgenual prefrontal cortex abnormalities in mood disorders , 1997, Nature.

[10]  R. S. Smith The macrophage theory of depression. , 1991, Medical hypotheses.

[11]  J. Jolles,et al.  Distinction Between Preclinical Alzheimer's Disease and Depression , 2000, Journal of the American Geriatrics Society.

[12]  R. Duman,et al.  Repeated stress increases catalytic TrkB mRNA in rat hippocampus , 1999, Neuroscience Letters.

[13]  B. Harvey Affective Disorders and Nitric Oxide: A Role in Pathways to Relapse and Refractoriness? , 1996 .

[14]  R Levy,et al.  Neuropsychological deficits and CT scan changes in elderly depressives , 1990, Psychological Medicine.

[15]  G. Buzsáki Large-scale recording of neuronal ensembles , 2004, Nature Neuroscience.

[16]  Seaver,et al.  Nitric oxide as a secretory product of mammalian cells , 2004 .

[17]  James T Becker,et al.  Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration. , 2002, The American journal of psychiatry.

[18]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  C. Nemeroff,et al.  Hypercortisolemia and hippocampal changes in depression , 1993, Psychiatry Research.

[20]  E. Traggiai,et al.  Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages , 2001, Journal of Neuroimmunology.

[21]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[22]  Glenda M MacQueen,et al.  Course of illness, hippocampal function, and hippocampal volume in major depression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Welsh-Bohmer,et al.  A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. , 1997, Biological psychiatry.

[24]  O. Hayaishi,et al.  Biochemical and medical aspects of tryptophan metabolism : proceedings of the third international meeting of the International Study Group for Tryptophan Research held in Kyoto, Japan, August 4-7, 1980 , 1980 .

[25]  D. Balota,et al.  Relating anatomy to function in Alzheimer's disease , 1998, Neurology.

[26]  J. Altman Autoradiographic and histological studies of postnatal neurogenesis. IV. Cell proliferation and migration in the anterior forebrain, with special reference to persisting neurogenesis in the olfactory bulb , 1969, The Journal of comparative neurology.

[27]  B. Brew,et al.  Kynurenine pathway metabolism in human astrocytes. , 1999, Advances in experimental medicine and biology.

[28]  H. Steinbusch,et al.  Efavirenz Induces Depressive-Like Behaviour, Increased Stress Response and Changes in the Immune Response in Rats , 2005, Neuroimmunomodulation.

[29]  E. Castrén,et al.  Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects , 2003, The Journal of Neuroscience.

[30]  Michael A Rapp,et al.  Neuropsychological differences between late-onset and recurrent geriatric major depression. , 2005, The American journal of psychiatry.

[31]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Yvette I. Sheline,et al.  Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression , 1999, The Journal of Neuroscience.

[33]  C. Lyketsos,et al.  Depression in Alzheimer’s disease: overview and treatment , 2002, Biological Psychiatry.

[34]  W. Drevets,et al.  The cellular neurobiology of depression , 2001, Nature Medicine.

[35]  K. Marder,et al.  Factors associated with incident human immunodeficiency virus-dementia. , 2001, Archives of neurology.

[36]  B. Reisberg,et al.  Vascular cognitive impairment , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[37]  B. McEwen,et al.  Possible mechanisms for atrophy of the human hippocampus , 1997, Molecular Psychiatry.

[38]  J. Orav,et al.  Depression in multiple sclerosis. , 1987, General hospital psychiatry.

[39]  Michael A Rapp,et al.  Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. , 2006, Archives of general psychiatry.

[40]  R. Green,et al.  Depression as a risk factor for Alzheimer disease: the MIRAGE Study. , 2003, Archives of neurology.

[41]  C. Cotman,et al.  Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus , 2000, Neuroscience.

[42]  C. Shatz,et al.  Synaptic Activity and the Construction of Cortical Circuits , 1996, Science.

[43]  B. Stanfield,et al.  Evidence that granule cells generated in the dentate gyrus of adult rats extend axonal projections , 2004, Experimental Brain Research.

[44]  R. Grant,et al.  Murine Glial Cells Regenerate NAD, After Peroxide‐Induced Depletion, Using Either Nicotinic Acid, Nicotinamide, or Quinolinic Acid as Substrates , 1998, Journal of neurochemistry.

[45]  P. Landfield,et al.  Evolving aspects of the glucocorticoid hypothesis of brain aging: Hormonal modulation of neuronal calcium homeostasis , 1994, Neurobiology of Aging.

[46]  L. Crnic,et al.  Anxiety Behavior, Exploratory Behavior, and Activity in NZB × NZW F1 Hybrid Mice: Role of Genotype and Autoimmune Disease Progression , 1996, Brain, Behavior, and Immunity.

[47]  J. John Mann,et al.  Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.

[48]  D. Blazer Depression in late life: review and commentary. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[49]  Y. Kim,et al.  Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. , 2003, Medical hypotheses.

[50]  C. Pariante,et al.  Glial cell abnormalities in major psychiatric disorders: the evidence and implications , 2001, Brain Research Bulletin.

[51]  T. F. O'Brien,et al.  Multipotent Stem/Progenitor Cells with Similar Properties Arise from Two Neurogenic Regions of Adult Human Brain , 1999, Experimental Neurology.

[52]  Bin Liu,et al.  Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.

[53]  R. Pihl,et al.  Tryptophan depletion causes a rapid lowering of mood in normal males , 2004, Psychopharmacology.

[54]  S. Moncada,et al.  International Union of Pharmacology Nomenclature in Nitric Oxide Research. , 1997, Pharmacological reviews.

[55]  M. Miller,et al.  High-dimensional mapping of the hippocampus in depression. , 2003, The American journal of psychiatry.

[56]  E. Major,et al.  A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. , 1993, Brain : a journal of neurology.

[57]  R. Sapolsky,et al.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. , 2000, Archives of general psychiatry.

[58]  Eric J. Nestler,et al.  Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus , 2000, The Journal of Neuroscience.

[59]  H. Steinbusch,et al.  Kynurenine pathway in major depression: evidence of impaired neuroprotection. , 2007, Journal of affective disorders.

[60]  B. Leonard Brain cytokines and the psychopathology of depression , 2001 .

[61]  B. Leonard,et al.  Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. , 1994, Journal of affective disorders.

[62]  Mikko Sairanen,et al.  Brain-Derived Neurotrophic Factor and Antidepressant Drugs Have Different But Coordinated Effects on Neuronal Turnover, Proliferation, and Survival in the Adult Dentate Gyrus , 2005, The Journal of Neuroscience.

[63]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[64]  C. Song,et al.  The comparison of changes in behavior, neurochemistry, endocrine, and immune functions after different routes, doses and durations of administrations of IL-1beta in rats. , 2006, Pharmacopsychiatry.

[65]  J. Altman,et al.  Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats , 1965, The Journal of comparative neurology.

[66]  R. Hen,et al.  Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants , 2003, Science.

[67]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[68]  I. Wicks,et al.  Molecular targets in immune‐mediated diseases: the case of tumour necrosis factor and rheumatoid arthritis , 2003, Immunology and cell biology.

[69]  B. Brew,et al.  Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons , 2005, Glia.

[70]  Norio Matsuki,et al.  Microglia‐specific expression of microsomal prostaglandin E2 synthase‐1 contributes to lipopolysaccharide‐induced prostaglandin E2 production , 2005, Journal of neurochemistry.

[71]  D. Choi,et al.  Quinolinate neurotoxicity in cortical cell culture , 1987, Neuroscience.

[72]  J. Klein Functions and pathophysiological roles of phospholipase D in the brain , 2005, Journal of neurochemistry.

[73]  T. Stone,et al.  An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid , 1982, Brain Research.

[74]  M. Poo,et al.  The cell biology of neuronal navigation , 2001, Nature Cell Biology.

[75]  A. Valentine,et al.  Neurological and Psychiatric Adverse Effects of Immunological Therapy , 1995 .

[76]  P. Modrego,et al.  Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. , 2004, Archives of neurology.

[77]  R. Duman Novel therapeutic approaches beyond the serotonin receptor , 1998, Biological Psychiatry.

[78]  J. Csernansky,et al.  Hippocampal atrophy in recurrent major depression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  E. Vittinghoff,et al.  Depressive affect and survival among gay and bisexual men infected with HIV. , 1996, Archives of internal medicine.

[80]  E. Major,et al.  Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. , 1992, The Biochemical journal.

[81]  M. Maes,et al.  IDO and interferon-α-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity , 2005, Molecular Psychiatry.

[82]  J T O'Brien,et al.  Clinical and Magnetic Resonance Imaging Correlates of Hypothalamic–Pituitary–Adrenal Axis Function in Depression and Alzheimer's Disease , 1996, British Journal of Psychiatry.

[83]  M Ashtari,et al.  Hippocampal/amygdala volumes in geriatric depression , 1999, Psychological Medicine.

[84]  G. Adler,et al.  Post-dexamethasone cortisol level and memory performance in elderly depressed patients , 2001, Neuroscience Letters.

[85]  B. Brew,et al.  Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection , 2001, Journal of neurochemistry.

[86]  K. Krishnan,et al.  Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. , 1992, Archives of general psychiatry.

[87]  M. Shenton,et al.  Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma , 2002, Nature Neuroscience.

[88]  Stephen J. Smith,et al.  Neural activity and the dynamics of central nervous system development , 2004, Nature Neuroscience.

[89]  S. Cohen-Cory The Developing Synapse: Construction and Modulation of Synaptic Structures and Circuits , 2002, Science.

[90]  S. Cuzzocrea,et al.  Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. , 2001, Pharmacological reviews.

[91]  R. Duman,et al.  Activation of cAMP Signaling Facilitates the Morphological Maturation of Newborn Neurons in Adult Hippocampus , 2004, The Journal of Neuroscience.

[92]  James R MacFall,et al.  Hippocampal volume in geriatric depression , 2000, Biological Psychiatry.

[93]  T. Stone,et al.  Endogenous kynurenines as targets for drug discovery and development , 2002, Nature Reviews Drug Discovery.

[94]  David C. Steffens,et al.  A twin study of late-onset depression and apolipoprotein E ε4 as risk factors for alzheimer's disease , 1997, Biological Psychiatry.

[95]  P. Marshall Allergy and depression: a neurochemical threshold model of the relation between the illnesses. , 1993, Psychological bulletin.

[96]  Z. Kronfol,et al.  Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls , 1989, Acta psychiatrica Scandinavica.

[97]  S. Wesselingh,et al.  Elevated central nervous system prostaglandins in human immunodeficiency virus—associated dementia , 1994, Annals of neurology.

[98]  P. Greengard,et al.  Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[99]  J. Altman,et al.  Autoradiographic and histological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incoorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions , 1966, The Journal of comparative neurology.

[100]  B. Mulsant,et al.  The temporal relationship between depressive symptoms and dementia: a community-based prospective study. , 1999, Archives of general psychiatry.

[101]  T. Smith,et al.  Low natural killer cytotoxicity in major depression. , 1987, Life sciences.

[102]  E. Bosmans,et al.  Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. , 1997, Cytokine.

[103]  R. Post,et al.  Effects of Stress on Neurotrophic Factor Expression in the Rat Brain , 1995, Annals of the New York Academy of Sciences.

[104]  Anil Gholkar,et al.  A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. , 2004, The American journal of psychiatry.

[105]  J. Siuciak,et al.  Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures , 1999, Neuroscience.

[106]  E. Bosmans,et al.  The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. , 1998, Journal of affective disorders.

[107]  R. Schiffer,et al.  Affective disorders in multiple sclerosis. Review and recommendations for clinical research. , 1990, Archives of neurology.

[108]  D. H. Bell,et al.  Neuronal proliferation in the 9-month-old rodent — Radioautographic study of granule cells in the hippocampus , 2004, Experimental Brain Research.

[109]  D. Longo,et al.  Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. , 1994, Blood.

[110]  B. Sahakian,et al.  Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed , 1996, Psychological Medicine.

[111]  G. Niederehe,et al.  Depression and memory impairment: a meta-analysis of the association, its pattern, and specificity. , 1995, Psychological bulletin.

[112]  B. Lebowitz,et al.  Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[113]  C. Coffey,et al.  Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.

[114]  J. Calabrese,et al.  Depression, immunocompetence, and prostaglandins of the E series , 1986, Psychiatry Research.

[115]  E. Bosmans,et al.  Indicators of immune activation in major depression , 1996, Psychiatry Research.

[116]  L. Staib,et al.  Hippocampal volume reduction in major depression. , 2000, The American journal of psychiatry.

[117]  Eric Vermetten,et al.  Childhood trauma associated with smaller hippocampal volume in women with major depression. , 2002, The American journal of psychiatry.

[118]  E. Borden,et al.  Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. , 1987, Journal of immunology.

[119]  B. Leonard,et al.  Changes in the immune system in depression and dementia: causal or coincidental effects? , 2006, Dialogues in clinical neuroscience.

[120]  H. Steinbusch,et al.  Th1, Th2, and Th3 cytokine alterations in major depression. , 2005, Journal of affective disorders.

[121]  A. Beekman,et al.  Depression and risk of cognitive decline and Alzheimer's disease , 2000, British Journal of Psychiatry.

[122]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[123]  David C. Steffens,et al.  Structural neuroimaging and mood disorders: Recent findings, implications for classification, and future directions , 1998, Biological Psychiatry.

[124]  M Ashtari,et al.  Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease? , 1997, Psychological Medicine.

[125]  Bruce S. McEwen,et al.  Course of Illness, Hippocampal Function, and Hippocampal Volume in Major Depression , 2005 .

[126]  W. Katon,et al.  Depression and chronic medical illness. , 1990, The Journal of clinical psychiatry.